Union Minister of Health and Family Welfare, Shri Jagat Prakash Nadda, today reviewed the progress and initiatives of the Indian Pharmacopoeia Commission (IPC), in the presence of Ms. Nivedita Shukla Verma, Secretary, Department of Chemicals and Petro-Chemicals (DoCP) and holding additional charge as Secretary, MoHFW.  

Shri Nadda appreciated IPC’s sustained efforts in strengthening pharmacopoeial standards and pharmacovigilance activities, which contribute to the Government’s vision of Atmanirbhar Bharat and a Viksit Bharat, promoting self-reliance, scientific excellence, and robust healthcare standards.

During the review, Shri Nadda commended IPC for its pivotal role in ensuring the quality, safety, and efficacy of medicines, thereby protecting public health. He noted that the Indian Pharmacopoeia remains a critical scientific and regulatory reference, ensuring uniform standards of medicines across the country.

The Minister highlighted that “the Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities.” He observed that “this recognition strengthens India’s position as the Pharmacy of the World and underscores the credibility of Indian pharmacopoeial standards globally.”

In addition to this, the 10^th edition of the Indian Pharmacopoeia 2026 is scheduled to be launched by the Union Health Minister in the first week of January, 2026.

In the meeting, Shri Nadda emphasized IPC’s crucial role in implementing the Pharmacovigilance Programme of India (PvPI) to monitor adverse drug reactions and ensure patient safety, and appreciated its efforts to strengthen reporting systems and build capacity among healthcare professionals. He also lauded IPC’s contribution to Atmanirbhar Bharat through strengthening indigenous scientific expertise and regulatory standards, while supporting global public health. The Minister encouraged IPC to continue focusing on innovation, digitalisation, and global harmonisation of standards in line with the vision of Viksit Bharat, to ensure universal access to safe and quality medicines.

The details of the activities were presented by Dr. V. Kalaiselvan, Secretary-cum-Scientific Director (IPC) and he further reaffirmed the commitment to further strengthen pharmacopoeial and pharmacovigilance standards, enhancing international collaboration and contributing to national and global health objectives.

Shri Harsh Mangla, Joint Secretary, MoHFW and other senior officers of the Ministry were also present at the meeting.

****

SR

HFW/HFM-IPC Review Meeting/26December2025/1